In another study, Empagliflozin, a sodium-glucose cotransporter 2 inhibitor that increases plasma ketone bodies60,61, was found to reduce aortic aneurysm diameter and aortic wall RANTES in Apoe−/− mice62. The gene discussed is SLC5A2; the disease is aortic aneurysm.